Literature DB >> 21990472

Microsurgical and endovascular management of pericallosal aneurysms.

Ferdinand K Hui1, Albert J Schuette, Shaye I Moskowitz, Alejandro M Spiotta, Michael L Lieber, Peter A Rasmussen, Jacques E Dion, Daniel L Barrow, C Michael Cawley.   

Abstract

BACKGROUND: Pericallosal, or A2 bifurcation, aneurysms are an infrequently encountered cause of subarachnoid hemorrhage (SAH). While the International Subarachnoid Aneurysm Trial showed improved outcomes for patients with any ruptured anterior circulation aneurysm treated with embolization, there was also a higher recurrence rate for embolized aneurysms. Notably, there were relatively few pericallosal aneurysms.
OBJECTIVE: Specific analysis of pericallosal aneurysms may help guide therapeutic decisions.
METHODS: Retrospective analysis of patients who presented with proven saccular pericallosal aneurysms was performed at two institutions from 1999 to 2009. Patients were stratified according to presentation Hunt and Hess grades and modified Fisher scores, treatment modality and outcomes as well as development of vasospasm, hydrocephalus and required treatment.
RESULTS: Eighty-eight patients with pericallosal aneurysms were identified. Sixty-two presented with SAH and 26 in elective fashion, 2 of whom had a prior history of SAH. Fifty-four patients underwent microsurgical repair and 32 endovascular repair. Patients presenting with SAH due to pericallosal aneurysm treated with an endovascular approach were more likely to have a good modified Rankin scale (mRS) (mRS 0-2 vs 3-6) (p=0.028), to make a complete recovery (mRS=0) (p=0.017) and were less likely to die (mRS=6) (p=0.026). Patients with electively treated pericallosal aneurysms did not have statistically significant differences in outcome between surgical and endovascular cohorts. Differences in secondary endpoints did not reach significance.
CONCLUSION: Patients with ruptured pericallosal aneurysms fare better with endovascular therapy, with better chance of complete recovery. Surgical and endovascular treatments of unruptured pericallosal aneurysms have similar results and outcome.

Entities:  

Mesh:

Year:  2011        PMID: 21990472     DOI: 10.1136/jnis.2011.004770

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  5 in total

Review 1.  Endovascular treatment of distal anterior cerebral artery aneurysms: single-center experience and a systematic review.

Authors:  C L Sturiale; W Brinjikji; M H Murad; H J Cloft; D F Kallmes; G Lanzino
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-18       Impact factor: 3.825

Review 2.  Mirror image distal anterior cerebral artery aneurysms treated with coil embolization. a report of two cases and literature review.

Authors:  E Enesi; A Rroji; M Demneri; G Vreto; M Petrela
Journal:  Interv Neuroradiol       Date:  2013-03-04       Impact factor: 1.610

3.  Pipeline Embolization Device for Pericallosal Artery Aneurysms: A Retrospective Single Center Safety and Efficacy Study.

Authors:  Katyucia De Macedo Rodrigues; Anna Luisa Kühn; Takamitsu Tamura; Guilherme Dabus; Peter Kan; Miklos G Marosfoi; J Diego Lozano; Mary Perras; Christopher Brooks; Mary C Howk; Samuel Y Hou; David E Rex; Francesco Massari; Matthew J Gounis; Ajay K Wakhloo; Ajit S Puri
Journal:  Oper Neurosurg (Hagerstown)       Date:  2018-04-01       Impact factor: 2.703

4.  Trends and Outcomes of Endovascular Embolization and Surgical Clipping for Ruptured Intracranial Aneurysms: A Propensity-Matched Study of 1332 Patients in the United States.

Authors:  Anna M Nia; Rishi R Lall; Peter Kan; Visish M Srinivasan
Journal:  World Neurosurg       Date:  2022-02-24       Impact factor: 2.210

5.  Current treatment options and prognostic factors for ruptured distal anterior cerebral artery aneurysms.

Authors:  Yushiro Take; Tomoya Kamide; Yuichiro Kikkawa; Masaki Ikegami; Akio Teranishi; Takuro Ehara; Aoto Shibata; Kaima Suzuki; Toshiki Ikeda; Satoshi Iihoshi; Shinya Kohyama; Hiroki Kurita
Journal:  Surg Neurol Int       Date:  2021-04-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.